Edition:
United Kingdom

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

4,719JPY
22 Mar 2019
Change (% chg)

¥-34 (-0.72%)
Prev Close
¥4,753
Open
¥4,800
Day's High
¥4,812
Day's Low
¥4,685
Volume
8,453,700
Avg. Vol
11,104,342
52-wk High
¥5,645
52-wk Low
¥3,498

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -69.71 March 23 Mar 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 5 5 5
(2) OUTPERFORM 11 9 8 7
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.73 1.64 1.62 1.58

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 3 838,432.00 936,787.00 778,300.00 --
Year Ending Mar-19 10 2,335,130.00 3,465,000.00 2,121,900.00 1,774,590.00
Year Ending Mar-20 11 3,499,180.00 3,630,800.00 3,050,000.00 1,844,830.00
Earnings (per share)
Quarter Ending Mar-19 3 -69.71 -21.50 -103.67 --
Year Ending Mar-19 8 141.62 270.15 51.60 204.34
Year Ending Mar-20 8 1.56 161.94 -78.90 230.52

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-18 488,240.00 499,402.00 11,162.00 2.29
Quarter Ending Jun-18 432,000.00 449,834.00 17,834.00 4.13
Quarter Ending Mar-18 410,578.00 400,963.00 9,615.00 2.34
Quarter Ending Dec-17 447,897.00 488,152.00 40,255.34 8.99
Quarter Ending Sep-17 438,894.00 433,176.00 5,718.00 1.30

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 838,432.00 789,254.00 789,254.00 -- --
Year Ending Mar-19 2,335,130.00 2,337,170.00 2,432,680.00 2,432,260.00 1,774,590.00
Year Ending Mar-20 3,499,180.00 3,492,930.00 3,490,630.00 3,511,820.00 1,844,830.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 0 0
Year Ending Mar-19 0 0 0 2
Year Ending Mar-20 0 0 1 1
Earnings